These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 12951334

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Activities of telithromycin against 13,874 Streptococcus pneumoniae isolates collected between 1999 and 2003.
    Farrell DJ, Felmingham D.
    Antimicrob Agents Chemother; 2004 May; 48(5):1882-4. PubMed ID: 15105150
    [Abstract] [Full Text] [Related]

  • 3. Macrolide and ketolide resistance with Streptococcus pneumoniae.
    Doern GV.
    Med Clin North Am; 2006 Nov; 90(6):1109-24. PubMed ID: 17116439
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacodynamic profile of telithromycin against macrolide- and fluoroquinolone-resistant Streptococcus pneumoniae in a neutropenic mouse thigh model.
    Tessier PR, Mattoes HM, Dandekar PK, Nightingale CH, Nicolau DP.
    Antimicrob Agents Chemother; 2005 Jan; 49(1):188-94. PubMed ID: 15616295
    [Abstract] [Full Text] [Related]

  • 8. High-level telithromycin resistance in a clinical isolate of Streptococcus pneumoniae.
    Wolter N, Smith AM, Low DE, Klugman KP.
    Antimicrob Agents Chemother; 2007 Mar; 51(3):1092-5. PubMed ID: 17210764
    [Abstract] [Full Text] [Related]

  • 9. Telithromycin (Ketek) for respiratory infections.
    Med Lett Drugs Ther; 2004 Aug 16; 46(1189):66-8. PubMed ID: 15314586
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. High prevalence of the ermB gene among erythromycin-resistant streptococcus pneumoniae isolates in Germany during the winter of 2000-2001 and in vitro activity of telithromycin.
    Kresken M, Henrichfreise B, Bagel S, Brauers J, Wiedemann B.
    Antimicrob Agents Chemother; 2004 Aug 16; 48(8):3193-5. PubMed ID: 15273149
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. In vitro activities of telithromycin, linezolid, and quinupristin-dalfopristin against Streptococcus pneumoniae with macrolide resistance due to ribosomal mutations.
    Farrell DJ, Morrissey I, Bakker S, Buckridge S, Felmingham D.
    Antimicrob Agents Chemother; 2004 Aug 16; 48(8):3169-71. PubMed ID: 15273142
    [Abstract] [Full Text] [Related]

  • 14. Comparative activity of telithromycin against macrolide-resistant isolates of Streptococcus pneumoniae: results of two years of the PROTEKT surveillance study.
    Schito GC, Marchese A, Elkharrat D, Farrell DJ, PROTEKT Study Group.
    J Chemother; 2004 Feb 16; 16(1):13-22. PubMed ID: 15077994
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pneumococcal resistance to macrolides, lincosamides, ketolides, and streptogramin B agents: molecular mechanisms and resistance phenotypes.
    Edelstein PH.
    Clin Infect Dis; 2004 May 15; 38 Suppl 4():S322-7. PubMed ID: 15127365
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.